# data[].attributes.body
My top 5 strengths

1. Significance- I want to make an impact. I am independent and prioritize projects bases on how they influence my organization and the people around me.

2. Achiever- I take immense satisfaction in being busy and productive. I work had and have a great deal of stamina.

3. Activator- Thoughts into actions please! I want to do things now rather than simply talk about them.

4. Positivity- My enthusiasm can be contagious. I am upbeat and have the ability to get others excited!

5. Woo!!- I love the challenge of meeting new people and winning them over. I can be an icebreaker and love making connections with people.

My team

Responsible Randall! You'e first up on my team because I need someone to balance out the activator in me. You are reliability and honesty. You are accountable to your word and I think you have just what we need to keep this project on track.

Analytical Angelica I want you too! I love the way you think. Your search for reason and rational will help stimulate the group into think though this project more logically. You will be able to help us chart our way to success!

Developer Daisy.. you my friend are so needed on this project. I love the way you grow talent in others. You're a great teacher and coach. You will be able to see the small wins as we venture into this project and help us celebrate each small win as a group.

Maximizer Matthew! You are the one we need to take a great project and make it into a superior project! You will be the one to stimulate group and personal excellence. You will push us to our maximum potential!

Restorative Rachel will be the team member that helps solve the problems. You are able to figure out the hurdles in the project and help the team leap over any obstacle. You are the troubleshooter of the group.

# data[].attributes.body
Spravato became FDA approved to treat treatment-resistant depression (TRD) in adults March 5th, 2019.

The Food and Drug Administration (FDA) announced Aug. 3 2020 the additional approval for the expanded use of SPRAVATO esketamine Clll nasal spray for the treatment of major depressive disorder (MDD) with acute suicidal ideation or behavior.

# data[].attributes.attachment_link.title
SPRAVATO® (esketamine) | Official Patient Website

# data[].attributes.attachment_link.description
SPRAVATO® (esketamine) Official Consumer Website. See full Prescribing & Safety Information, including BOXED WARNINGS.

# data[].attributes.body
Depression is the third leading cause of disability in the world and one-third of patients are resistance to current drug treatment options. This is known as treatment-resistance depression (TRD). Depression affects approximately 350 million individuals worldwide and is cause for personal suffering and economic loss.

The use of ketamine in low doses for treatment of depression has been found to be effective in patients with TRD. Ketamine has a treatment onset of less that 24 hours in contrast to other anti-depressive medications that take up to four weeks to become effective. In some cases ketamine can works as quickly as 40 minutes. In conjunction with cognitive behavioral therapy, studies have shown that more than half the patients treated with ketamine or esketamine (nasal spray ketamine) have had significant improvement of their depressive symptoms.

# data[].attributes.body
BrainFacts.org. (2019, August 1st). How Ketamine treats depression. [Video].

# data[].attributes.body
Ketamine has the ability to create new neurotransmitter growth and hence "reprogram" the chemistry of the brain.

In conjunction with cognitive behavior therapy ketamine's reprogramming effects can lead to long term recovery of depression

Ketamine has a very rapid onset.

Ketamine's studies are showing effective resolution of depressions with small dosing (both via nasal route and IV routes of administration).

# data[].attributes.body
Ketamines long term effects are unknown.

Ketamine can be very addictive. Those patients prescribed ketamine are at risk for abuse and misuse of the medication.

Respiratory depression is a possible side effect of ketamine.

Ketamine can cause disassociation and patients should be monitored closely for psychosis.

# data[].attributes.body
Ketamine is showing a wide range of beneficial results in the treatment of TRD and MDD. Depression has such a major effect on our world, both directly and indirectly, new treatment options showing such amazing results in clinical trials need to be embraced and continued to be researched. We should continue to evaluate the effectiveness of ketamine as an approved treatment for depression and explore all this medication modality had to offer for our patients.

# data[].attributes.body
Canady, V. A. (2020). FDA approves esketamine treatment for MDD, suicidal ideation. Mental Health Weekly, 30(31), 6–7.

Corriger, A., & Pickering, G. (2019). Ketamine and depression: a narrative review. Drug design, development and therapy, 13, 3051–3067. https://doi.org/10.2147/DDDT.S221437

BrainFacts.org. (2019, August 1st). How Ketamine treats depression. [Video].